Meverine SR 200 mg (Capsule (Sustained Release))
Medicine Details
Category | Details |
---|---|
Generic | Mebeverine hydrochloride |
Company | Drug international ltd |
Also available as |
Indications
- Symptomatic treatment of irritable bowel syndrome (IBS)
- Chronic irritable colon
- Spastic constipation
- Mucous colitis
- Colicky abdominal pain
- Persistent non-specific diarrhea
Description
Musculotropic antispasmodic agent used to relieve cramps or spasms of the stomach and intestine
Dosage & Administration
- Mebeverine Hydrochloride 135 mg tablet: 1 tablet 03 times daily
- Mebeverine Hydrochloride 200 mg capsule: 1 capsule 02 times daily
- Most effective when taken 20 minutes before meals
Missed Dose
If a dose is missed, take as soon as possible; however, do not double the dose to compensate
Use in Children
Not recommended for children under 10 years
Contraindications
Hypersensitivity to the drug or any other ingredients
Side Effects
Well tolerated; few side-effects like skin rash, urticaria, and angioedema may appear
Pregnancy & Lactation
No teratogenicity shown in animal experiments; usual precautions during pregnancy should be exercised; does not excrete in breast milk after administering at therapeutic dose
Precautions & Warnings
Caution in porphyria or allergic reaction to this or any other medicine of this group
Overdose Effects
CNS excitability may occur in case of overdosage; no specific antidote known; gastric lavage and symptomatic treatment recommended
Therapeutic Class
Anticholinergics
Storage Conditions
Do not store above 30°C; keep away from light and out of the reach of children
Related Brands
- Mevin 135 mg (Tablet) - square-pharmaceuticals-plc
- Rostil 135 mg (Tablet) - beximco-pharmaceuticals-ltd
- Veripel SR 200 mg (Capsule (Sustained Release)) - beacon-pharmaceuticals-plc
- A-Meb 135 mg (Tablet) - acme-laboratories-ltd
- Rostil SR 200 mg (Capsule (Sustained Release)) - beximco-pharmaceuticals-ltd